All News

A farmer in Ireland who was arrested for growing and selling cannabis from his farm received a suspended sentence. Currently, cannabis is illegal in Ireland, except within a limited medical program.

A recent study from the University of Connecticut showed that the new “retipping” method of propagation resulted in quality cannabis flowers while using less space.

In results from a recent study, respondents reported that cannabis use led them to decrease their use of pharmacological treatments, including opioids.

Starting January 1, 2023, every insurance provider in Colombia must cover the costs of medical cannabis prescriptions for patients.

Village Farms International, Inc., announced that starting later this month it will increase its global presence by beginning to ship cannabis products to the Israeli medical market.

In December, the US Department of Agriculture (USDA) announced an extension of the deadline for all hemp to be tested for tetrahydrocannabinol (THC) in Drug Enforcement Administration (DEA)-certified facilities only, citing a lack of approved laboratories.

Brittany Griner had been arrested in Moscow, Russia and sentenced to prison for cannabis possession, which is illegal in Russia.

On December 2nd, 2022, President Joe Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act, the first piece of standalone cannabis legislation in US history to become law. It will reportedly streamline a new process for cannabis research applications and for manufacturing products for drug development and allow for a larger amount of legal cannabis for research purposes.

In partnership with the Cannabis Center of Excellence, MCR Labs Massachusetts held their second “Cannabis Science Fair” on the afternoon of December 3rd, 2022, as the final event of their Science Over Stigma campaign.

In their 2022 Census of Agriculture, the US Department of Agriculture will, for the first time, collect and publish data on farmers and producers who grow hemp for fabric, food products, and cannabidiol (CBD).

The Cannabis & Me research study will reportedly study the effects of cannabis on the human brain, particularly in terms of a user’s prior psychological conditions.

International company PQE Group announced in late October their first ever start-up to provide support for medical cannabis.

For the first time, the Association of Official Analytical Collaboration (AOAC) INTERNATIONAL Research Institute granted its Reviewed and Recognized certification to a cannabis potency testing laboratory.

Earlier this month, Committee D37 on Cannabis, a committee within ASTM International, released descriptions of their four new standards for cannabis testing and who they will benefit within the industry.

In a recent announcement, Major League Baseball announced a sponsorship deal with cannabidiol (CBD) company Charlotte’s Web.

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

In a statement released from the White House on October 6, 2022, President Joe Biden announced plans to pardon Federal convictions for simple possession of marijuana and issued a call to review the scheduling of cannabis (1).

The Association of Official Analytical Collaboration (AOAC) INTERNATIONAL announced the winners of more than a dozen awards presented at their Annual Meeting.

Recently, some major food and beverage companies expressed interest in selling products containing cannabidiol (CBD), but the Food and Drug Administration (FDA) have not indicated any regulatory progress.

Cannabis Science Conference East was held in Baltimore, Maryland from September 14-16, 2022. Here we provide a few highlights from the event.

In a presentation for the psychedelics track at Cannabis Science Conference East 2022, Janie Maedler, Vice President of Rylie’s Smile Foundation and President of Rylie’s Sunshine LLC, led a panel discussion with Rylie Maedler, President of Rylie’s Smile and CEO of Rylie’s Sunshine LLC; Rita Lynn Lawrence, a cannabis patient advocate; and University of Miami cannabis epidemiologist Dr. Denise Vidot. The presentation titled “Psychedelics for Beginners” discussed the basics of using psychedelics for treating mental health issues safely and successfully. Here are some highlights from the session.

In his presentation for the psychedelics track at Cannabis Science Conference East 2022, James Schwartz, BSN, LNC, presented “A New Beginning for an Old Therapy: Case Series Review on the Treatment of PTSD and Other Psychiatric Disorders with Psilocybin and Other Psychedelics.” He reviewed the current research and clinical trials studying the effects of psilocybin, plus side effects, potential uses, latest trends, disorders currently being studied, and potential future applications. Schwartz was a trauma trained nurse who worked in the Trauma/Critical Care ICU at Oregon Health and Science University. He is an experienced medical legal consultant and CEO of Cascade High. Here are some highlights from his session.

In his keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Matthew Johnson presented his talk “Psilocybin in the Treatment of Tobacco Addiction,” which reviewed the treatment of substance use disorders with classic psychedelics (5HT2A agonists) including LSD and psilocybin. Dr. Matthew Johnson, PhD, is the Susan Hill Ward Professor of Psychedelics at Johns Hopkins and is one of the world’s most widely published experts on psychedelics. Here are some highlights from his session.

In a keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Andrew Coop, Dr. Chad Johnson, and Dr. Leah Sera of the University of Maryland School of Pharmacy presented “There’S Room for Everyone: The Emerging Field of Psychedelic Therapeutics.” The talk focused on the history of psychedelics, “classical” and “nonclassical” psychedelics, the current clinical research studies on psychedelics, and the announcement of a master’s program in the Cannabis Science and Therapeutics program at the University of Maryland School of Pharmacy. Here are some highlights from the session.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

View our amazing agenda in the Final Program & Exhibitor Guide for Cannabis Science Conference East 2022!

Recently in France, 31 senators published a co-signed letter in the French newspaper “Le Monde,” calling for the launch of a consultation process to introduce new laws to legalize cannabis in France.

The National Institute on Drug Abuse (NIDA) recently posted a notice to Drug Enforcement Agency-approved cannabis manufacturers that they will soon be able to submit applications to supply cannabis for research purposes. Currently, NIDA has only worked with one cannabis farm for the past 50 years–the new cannabis supplier selected by NIDA would be the second federally authorized in the country.

Recently, Leafreport, an Israeli company that provides reviews and comparisons of cannabidiol (CBD) companies and products, released their 2022 report on their transparency analysis for 4384 CBD products.